Physician profile
Jacob Jabbour
NPI 1679912851
$16,044.74
in general payments reported to CMS, 2019-2025
27 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $483 · 2021: $1,891 · 2022: $3,827 · 2023: $5,351 · 2024: $3,404 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,651 · Consulting Fee: $2,000 · Travel and Lodging: $1,596 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,650.82 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,596.41 |
| Education | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $3,394.00 | 2019-2022 | |
| Biopro, INC. | $3,047.64 | 2023-2025 | Mod Thumb, Mod Thumb |
| Trice Medical, INC. | $3,031.75 | 2022-2025 | |
| Axogen | $1,940.53 | 2020-2025 | Avance Nerve Graft |
| Sonex Health, INC. | $1,623.35 | 2022-2025 | Sx-One Microknife |
| Skeletal Dynamics INC | $463.27 | 2024 | Align, Geminus, Ijs |
| Bone Support INC. | $368.94 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Endo Pharmaceuticals INC. | $351.27 | 2021-2024 | Xiaflex |
| Davol INC. | $291.75 | 2020 | |
| Somavac Medical Solutions, INC. | $233.76 | 2021-2022 | |
| Endo USA, INC. | $182.37 | 2024 | Xiaflex |
| Tepha INC | $170.35 | 2019 | |
| Tela Bio, INC. | $128.90 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $117.59 | 2021 | |
| Allergan, INC. | $115.97 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $115.91 | 2024 | Versawrap |
| Integra Lifesciences Corporation | $107.40 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $103.38 | 2023 | Actishield, Twinfix, Variax |
| Alnylam Pharmaceuticals INC. | $67.50 | 2024 | Onpattro |
| Smith+Nephew, INC. | $32.10 | 2025 | Stravix, Grafix |
| Ethicon US, LLC | $26.68 | 2024 | Vicryl |
| Kerecis Limited | $25.14 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $24.84 | 2019 | |
| Orthofix Medical, INC. | $21.41 | 2025 | Physio-Stim |
| Kls-Martin L.P. | $21.18 | 2021 | |
| Medela LLC | $19.68 | 2022 | |
| Sanara Medtech INC. | $18.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Jabbour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.